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Abstract 
Background: Infections due to resistant bacteria are associated with severe illness, increased risk for complications, 
hospital admissions, and higher mortality. Inappropriate use of antibiotics, which contributes to increased antibiotic 
resistance (ABR), is common in healthcare settings across the globe. In Cameroon, antibiotics have been reported 
as high as 45–70% of prescriptions. We sought to investigate the knowledge, attitudes, and perceptions regarding 
appropriate antibiotic use and ABR of medical doctors practicing in tertiary hospitals in Yaoundé, Cameroon.
Methods: We conducted a cross-sectional survey using a 54-item self-administered questionnaire sent via email to 
medical doctors working in the four major tertiary hospitals of Yaoundé. The questionnaire recorded socio-demo-
graphics, perceptions on antibiotic use and ABR, sources and usefulness of education on ABR, and clinical scenarios to 
appraise knowledge.
Results: A total of 98/206 (48%) doctors responded. Years of experience ranged between 1 and 17 years. Most par-
ticipants agreed that ABR is a problem nationwide (93%) and antibiotics are overused (96%), but only one third (32%) 
thought that ABR was a problem in their wards. Most respondents (65%) were confident that they use antibiotics 
appropriately. We found a mean knowledge score of 56% (± 14), with prescribers not influenced by patient-exerted 
pressure for antibiotic prescribing scoring better compared to those influenced by patients (67% vs 53%, p = 0.01). 
Overall, most participants (99%) expressed interest for further education on both appropriate antibiotic use and ABR.
Conclusion: Confidence of prescribers in their ability to appropriately use antibiotics conflicts with the low level of 
knowledge on antibiotic use in this group of doctors. Moreover, the opinion of the majority, that ABR is not a problem 
in their own backyard is in keeping with similar studies in other countries and is of significant concern. Introduction of 
formal antibiotic stewardship programmes in Cameroon may be a useful intervention.
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Background
The threat of antibiotic resistance (ABR) is growing at 
an alarming rate. The Centers for Diseases Control and 
Prevention (CDC) report more than 2.8 million antibi-
otic-resistant infections in the United States each year 
[1]. This is associated with high mortality with more than 
35,000 related deaths [1]. In Europe, more than 33,000 
deaths are due to antibiotic-resistant infections annu-
ally [2]. Despite limited laboratory capacity to monitor 
ABR; available data suggest that Africa shares the trend 
of increasing bacterial resistance. It has been estimated 
that by 2050, 10 million people will die each year from a 
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Any use of antibiotics, even appropriate, contributes 
to the development of resistance. Emergence of ABR 
is a natural phenomenon in response to selection pres-
sure imposed by an antibiotic, which allows selection of 
strains able to resist the action of that antibiotic. How-
ever, inappropriate use of antibiotics, which is associ-
ated with increased antibiotic resistance, can adversely 
impact the clinical outcome of patients. Infections due 
to resistant bacteria are associated with severe disease, 
increased risk of complications and hospital admission 
and higher mortality rate [4, 5]. Inappropriate use of anti-
biotics corresponds to the use of antibiotics without clin-
ical indications, use of an antibiotic not recommended 
for a condition, incorrect dose, duration and/or route of 
administration. The main drivers of inappropriate use 
of antibiotics at the health care worker (HCW)-level, 
include: (i) inadequate education of HCWs, (ii) prescrib-
er’s knowledge, attitudes and practices, (iii) pharmaceuti-
cal promotion, and (iv) patient–doctor interaction [6].
The overall goal of mitigating ABR is to preserve the 
effectiveness of antibiotics. Health care workers have an 
essential role to play in antibiotic stewardship, but their 
role may be jeopardized if their knowledge or practices 
are sub-optimal. CDC estimates that 30% (47 million 
antibiotics courses) of all antibiotics prescribed each year 
in outpatient clinics and emergency departments in the 
US are unnecessary [7]. A study on medicines prescribed 
in nine US nursing homes showed that at least half of 
the antibiotic prescriptions contained the wrong drug, 
dose, or duration [8]. This figure is not better in low- and 
middle-income countries (LMICs) where nearly half of 
patients with acute viral upper respiratory tract infec-
tions and viral diarrhoea are treated unnecessarily with 
antibiotics [9, 10]. A study assessing knowledge of antibi-
otic use in Democratic Republic of Congo (DRC) showed 
that 39% of HCWs had low knowledge scores and less 
than half of respondents could accurately estimate local 
resistance rates for Salmonella typhi and Klebsiella spp. 
[11]. If patients are to use antibiotics properly, HCWs 
need to counsel them correctly. Appropriate use of anti-
biotics has been associated with lower antibiotic con-
sumption and reduced incidence of antibiotic-resistant 
infections [12, 13]. In Cameroon, antibiotics make up 
45–70% of prescriptions but data on their use are lacking 
[14, 15]. Here, we report on the knowledge, attitudes, and 
perceptions of medical doctors towards antibiotic use 
and ABR in Cameroon with the goal of identifying gaps 
to be addressed to optimize antibiotics use.
Methods
Procedure
We conducted a cross-sectional survey from May 2018 to 
February 2019, targeting all medical doctors practicing in 
major tertiary hospitals of Yaoundé, Cameroon, namely 
General Hospital (YGH), Gynaeco-Obstetric and Pae-
diatrics Hospital (YGOPH), Central Hospital (YCH), 
and University Teaching Hospital (YUCH). The tertiary 
hospitals together employ approximatively 260 medi-
cal doctors including specialists, registrars, and general 
practitioners.
A convenience sampling was used. An email invita-
tion generated from Research Electronic Data Capture 
(REDCap) tools [16] hosted at University of Cape Town-
Department of Medicine, was sent to every doctor work-
ing in these hospitals. The purpose of the study was 
clearly explained in the aforementioned invitation email. 
The email was automatically resent after 10 days if there 
was no answer or if the questionnaire was not yet com-
pleted. This follow up period was subsequently reduced 
to 5 days after an initial low response rate. The invitation 
was resent up to five times.
The self-administered questionnaire comprised 54 
questions and ten clinical cases structured in four 
sections:
• Socio-demographics,
• Perceptions on the importance of ABR and the 
awareness about causes of ABR,
• Attitudes and practices in the choice of antibiotics 
and potential interventions to improve antibiotic use,
• Knowledge on ABR and antibiotic use rated based 
on ten clinical cases on: infection prevention and 
control (IPC), appropriate prescription of antibiotics 
(community-acquired infections, extended-spectrum 
β-lactamase (ESBL) Gram-negative infections), dura-
tion of therapy, de-escalation, and adverse effects of 
antibiotics.
The questions have been made simple and unambigu-
ous. The questionnaire was anonymous and was in Eng-
lish and French, the two official languages of Cameroon. 
The choice of the clinical cases and micro-organisms 
were based on the prevalence/frequency of the diseases 
in the selected hospitals irrespective of the wards’ spe-
cificities and are similar to the questions used in previous 
studies on knowledge, attitudes and practices on antibi-
otics use and antibiotics resistance [17].
Ethical considerations
Electronic informed consent was obtained from each 
participant. All procedures were approved by both the 
Human Research Ethics Committee of the University of 
Cape Town (HREC REF: 203/2018), South Africa, and 
the Ethics Committee for Human Health Research in the 
Centre Region, Cameroon (REF: 0548/CRERSHC/2018). 
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The study was performed in accordance with the Decla-
ration of Helsinki.
Statistical analysis
Descriptive statistics were used to characterize the total 
sample. Continuous variables were described using mean 
with standard deviation or median with interquartile 
range depending on the distribution of data. Propor-
tions were calculated for categorical variables. Compos-
ite scoring of perceptions and attitudes was based on the 
five-point Likert-type response scales: strongly agree/
agree/neutral/disagree/strongly disagree, strongly influ-
ence/influence/neutral/do not influence/do not influence 
at all, often/sometimes/rarely/never/not familiar, and 
very helpful/helpful/neutral/not helpful/not helpful at all 
[18]. Likert-type ratings (single survey questions) were 
summarised as proportions by collapsing the two catego-
ries on either side of the neutral category and creating 
an ordinal variable with three categories. The reported 
categories were therefore a positive response, a neutral 
response, or a negative response (e.g., agree/neutral/disa-
gree). For analysis of knowledge, each correct response 
was scored 1 while a wrong or doubtful response 0. The 
mean knowledge score was then calculated. The associa-
tion between the knowledge scores and composite scores 
of perceptions and attitudes expressed as Likert-type 
categories or baseline socio-demographic characteristics 
were compared using either one-way ANOVA test for 
variance or two-sample t-test respectively. Chi-square or 
Fisher’s Exact tests were used for assessing the differences 
between socio-demographic variables and perceptions/
attitudes questions expressed as Likert-type categories. A 
p-value < 0.05 was considered as statistically significant.
Results
Socio‑demographics
Of the 206 doctors invited to participate to the study, 98 
(48%) responded and 66% (65/98) completed the ques-
tionnaire in its entirety. The median age was 31  years 
(interquartile range (IQR) 29–34) and 55% were female. 
The majority of respondents were residents (60%) 
(Table 1).
Knowledge
The overall mean score on the knowledge question-
naire was 56% (± 14), with over a quarter (26%, 17/65) 
of participants scoring less than 50%. Participants scored 
well regarding the use of antibiotics for common infec-
tions—community acquired pneumonia (CAP) 71%, 
urinary tract infection (85%)—but scored poorly on 
Table 1 Socio-demographic characteristics of participants 
(N = 98)
GIT gastro-intestinal tract; ENT ear nose and throat; SD standard deviation; IQR 
interquartile range
Characteristic Distribution
Age in years, median (IQR) 31 (29–34)
Gender, n/N (%)
 Male 44 (45)
 Female 54 (55)
Cadre category, n/N (%)
 General practitioner 11 (11)
 Resident 59 (60)
 Specialist 24 (24)
 Unstated 4 (4)
Years as a medical doctor, median (IQR) 3 (2–6)
Years of residency, n/N (%)
 1st year resident 4/59 (7)
 2nd year resident 27/59 (46)
 3rd year resident 13/59 (22)
 4th year resident 15/59 (25)
Years as specialist, n/N (%)
 1–3 years 14/24 (58)
 4–6 years 7/24 (29)
 7–9 years 3/24 (13)
Cadre speciality, n/N (%)
 Cardiology 18/81 (22)
 Nephrology 9/81 (11)
 Obstetrics and gynaecology 7/81 (9)
 Endocrinology 6/81 (7)
 Internal medicine 6/81 (7)
 Surgery 6/81 (7)
 Paediatrics 4/81 (5)
 GIT 3/81 (4)
 Pathology 2/81 (3)
 Anaesthesia 1/81 (1)
 Ophthalmology 1/81 (1)
 ENT 1/81 (1)
 Oncology 1/81 (1)
 Neurology 1/81 (1)
 Infectious diseases 1/81 (1)
 Pulmonology 1/81 (1)
 General practitioner 10/81 (12)
 Unstated 3/81 (4)
Hospital, n/N (%)
 General Hospital 28 (29)
 Gynaeco-Obstetric and Paediatric Hospital 6 (6)
 Teaching Hospital 14 (14)
 Central Hospital 40 (41)
 Unstated 10 (10)
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antibiotic de-escalation (14%, 9/65) and duration of anti-
biotic prophylaxis (25%) (Table  2). Regarding the man-
agement of ESBL-E. coli infection, the choice of antibiotic 
was appropriate for 42% (27/65) of respondents.
When evaluating factors influencing doctor’s knowl-
edge, we found no correlation between the mean knowl-
edge score and a previous training on antibiotic use and 
resistance. The knowledge score was not influenced by 
the doctor’s category, specialty, age, experience, or prac-
tice location (hospital, ward). Moreover, perceptions on 
antibiotic use and ABR were not associated with knowl-
edge. Participants who do not mainly rely on textbooks 
as resources for antibiotics prescribing scored better than 
those who do (58% ± 13 vs 40% ± 12; p = 0.01) (Table 3). 
Doctors who were not influenced by patient pressure for 
antibiotic prescribing had a better knowledge score than 
those influenced by patients or those who were neutral 
(67% ± 12 vs 53% ± 13 or 62% ± 13; p = 0.01).
Education and source of information
When assessing common resources used by participants 
for antibiotics prescribing, we found that the most used 
were, in decreasing order of  frequency, textbooks (93%, 
68/73), professional/learned societies’ guidelines (93%, 
68/73), WHO  (World Health Organization) guidelines 
(81%, 59/73) and smart phones apps (60%, 44/73). Our 
results revealed that Infectious Diseases (ID) specialists 
are used as resources for antibiotic prescribing by only 
58% (42/73) of doctors surveyed. Most respondents rely 
on other colleagues (73%, 53/73) and consultants (54%, 
39/72) were the least utilised resource when prescribing 
antibiotics.
During the last 12 months, respondents attended a lec-
ture or workshop or course addressing the following top-
ics: diagnosis of infection (49%, 34/70), dose and duration 
of antibiotic therapy (43%, 30/70), indications for antibi-
otic use (34%, 24/70), spectrum of activity of commonly 
used antibiotics (23%, 16/70), indications for intravenous 
antibiotic use (21%, 15/70) and principles of Infection 
Prevention and Control (19%, 13/70). Nearly all partici-
pants agreed that medical journals (97%, 69/71) and con-
ferences (93%, 66/71) are useful resources for learning on 
antibiotic use and resistance. Pharmaceutical representa-
tives were considered useful resources by 44% (31/71) of 
respondents. It was almost unanimously felt (97%, 73/75) 
that development of local guidelines would be useful in 
improving antibiotic use and mitigating ABR. Further-
more, almost all respondents (99%, 74/75) were of the 
opinion that more education on antibiotic use and resist-
ance would be helpful.
Attitudes and perceptions on antibiotic use and antibiotic 
resistance
Most respondents, 93% (74/80) agreed that ABR is a 
significant problem in Cameroon, but only 40% (32/80) 
believed that it is a problem in their hospital wards. 
Interestingly, 54% (42/78) of doctors disagreed that poor 
hand hygiene is a cause for spread of antibiotic resistant 
bacteria (Fig. 1).
Despite acknowledgement by 96% (77/80) of partici-
pants that antibiotics are overused in Cameroon, only a 
third believed that antibiotics are overused in their ward 
(Fig. 1). Two-thirds (65%, 49/75) of prescribers were con-
fident that they use antibiotics optimally (Fig.  2). This 
confidence was not associated with the category of the 
prescriber, age, experience or previous education on anti-
biotic use, perceptions of antibiotic use and ABR, or level 
of knowledge.
Almost all respondents (97%, 73/75) agreed that inap-
propriate antibiotic use can harm patients (Fig. 2).
The leading factors influencing antibiotic prescribing 
were guidelines from learned societies and WHO (100%), 
quality of drug and cost effectiveness ratio (99% and 96% 
respectively), immunosuppression and/or critical clinical 
status of the patient (90%) (Table 4). Interestingly, patient 
expectations did not influence antibiotic prescription for 
71% of doctors.
Discussion
This study presents the first analysis of the knowledge, 
attitudes, and perceptions of physician’s use of antibiot-
ics at tertiary level hospitals in Cameroon. Awareness on 
antibiotic use and drivers of resistance are a critical first 
step to assist prescribers in using antibiotics appropri-
ately and optimally.
Participants in this study demonstrated a low level of 
knowledge and inaccurate perceptions on appropriate 
antibiotic use and ABR. These results are in keeping with 
Table 2 Summary of knowledge questions and answers
CAP community-acquired pneumonia; ESBL extended spectrum beta-
lactamases; UTI urinary tract infection
Topic Correct answer
n/N (%)
Contact precautions 42/66 (64)
Antibiotic therapy timing 64/66 (97)
Assessing severity and management of CAP 47/66 (71)
Management of acute diarrhoea 33/66 (50)
Antimicrobial selection for ESBL E. coli 27/65 (42)
Management of uncomplicated UTI 56/66 (85)
Interpretation of antibiogram and de-escalation 9/65 (14)
Peri-operative antibiotic prophylaxis 16/65 (25)
Antibiotics stop/review date 55/66 (83)
Management of C. difficile 29/66 (44)
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Table 3 Factors influencing knowledge
Characteristic Knowledge score p value
Professional category, mean (± SD)
 GP 49 (15) 0.16
 Resident 56 (14)
 Specialist 61 (14)
Hospital, mean (± SD)
 General Hospital 59 (13) 0.64
 Gynaeco-Obstetric and Paediatrics Hospital 58 (13)
 Teaching Hospital 58 (13)
 Central Hospital 54 (15)
Experience as medical officer mean (± SD)
 ≤ 3 years 53 (15) 0.19
 > 3 years 58 (13)
Experience as specialist, mean (± SD)
 ≤ 3 years 60 (14) 0.53
 > 3 years 64 (11)
Years of residency mean (± SD)
 ≤ 2 years 54 (13) 0.38
 > 2 years 58 (14)
Previous training on dosing and duration of antibiotic therapy, mean (± SD)
 Yes 57 (14) 0.83
 No 56 (14)
Previous training on principles of infection prevention and control, mean (± SD)
 Yes 58 (17) 0.54
 No 56 (14)
Personal previous experience, mean (± SD)
 Do not influence at all/do not influence 56 (14) 0.61
 Neutral 52 (15)
 Influence/strongly influence 60 (19)
Perceptions and attitudes
 Patient reassurance, mean (± SD)
  Do not influence at all/ do not influence 67 (12) 0.01
  Neutral 62 (13)
  Influence/strongly influence 53 (13)
 Antibiotic resistance profile in the hospital/ward, mean (± SD)
  Do not influence at all/ do not influence 56 (13) 0.07
  Neutral 60 (14)
  Influence/strongly influence 40 (17)
 Risk of missing an infection, mean (± SD)
  Do not influence at all/ do not influence 55 (14) 0.27
  Neutral 54 (14)
  Influence/strongly influence 61 (13)
 Patient immunocompromised or critically ill, mean (± SD)
  Do not influence at all/ do not influence 57 (14) 0.27
  Neutral 57 (15)
  Influence/strongly influence 43 (15)
 Pharmaceutical firms pressure, mean (± SD)
  Do not influence at all/ do not influence 56 (12) 0.95
  Neutral 57 (14)
  Influence/strongly influence 56 (15)
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Table 3 (continued)
Characteristic Knowledge score p value
 Antibiotic overuse in Cameroon, mean (± SD)
  Strongly disagree/disagree 56 (14) 0.51
  Neutral 45 (7)
  Agree/strongly agree 60 (-)
 Antibiotic overuse in the hospital, mean (± SD)
  Strongly disagree/disagree 56 (15) 0.66
  Neutral 58 (13)
  Agree/strongly agree 54 (13)
 Antibiotic overuse in ward* 0.30
  Strongly disagree/disagree 60 (13)
  Neutral 56 (15)
  Agree/strongly agree 54 (14)
 Antibiotic resistance in Cameroon
  Strongly disagree/disagree 56 (14) 0.88
  Neutral 60 (20)
  Agree/strongly agree 57 (6)
 Antibiotic resistance in hospital
  Strongly disagree/disagree 57 (14) 0.38
  Neutral 53 (14)
  Agree/strongly agree (11) 59 (12)
 Antibiotic resistance in ward
  Strongly disagree/disagree 57 (14) 0.95
  Neutral 56 (14)
  Agree/strongly agree 56 (14)
Resources used for antibiotic prescribing
 Infectious diseases specialist, mean (± SD)
  Not familiar/never 57 (13) 0.69
  Rarely 55 (16)
  Sometimes/Often 53 (14)
 Other consultants, mean (± SD)
  Not familiar/never 55 (13) 0.73
  Rarely 58 (15)
  Sometimes/Often 54 (18)
 Other colleagues, mean (± SD)
  Not familiar/never 55 (15) 0.51
  Rarely 58 (12)
 Textbooks, mean (± SD)
  Not familiar/never 58 (13) 0.01
  Rarely 40 (12)
 WHO guidelines, mean (± SD)
  Not familiar/never 57 (14) 0.73
  Rarely 54 (16)
  Sometimes/Often 50 (0)
 Learned society guidelines, mean (± SD)
  Not familiar/never 57 (13) 0.21
  Rarely 48 (24)
Page 7 of 11Domche Ngongang et al. BMC Infect Dis         (2021) 21:1116  
previous studies in LMICs [11, 19]. In a country where 
45–70% of drug prescriptions include at least one anti-
biotic, the absence of national and local guidelines on 
antibiotic prescribing together with insufficient HCWs 
training on antibiotic use and ABR could explain these 
findings [14, 15]. Moreover, there is a lack of ID special-
ists even at the higher level of health institutions. Medical 
doctors working in tertiary level hospitals are supposed 
to be the most trained on appropriate antibiotic pre-
scribing and ABR; they are also supposed to contribute 
Table 3 (continued)
Characteristic Knowledge score p value
 iPad/smart phone apps, mean (± SD)
  Not familiar/never 55 (14) 0.56
  Rarely 59 (15)
  Sometimes/Often 58 (13)
 Ward round
  Not helpful at all/not helpful 55 (14) 0.52
  Neutral 61 (11)
  Helpful/very helpful 60 (-)
 Conferences
  Not helpful at all/not helpful 56 (14) 0.52
  Neutral 60 (10)
 Pharmaceutical representatives
  Not helpful at all/not helpful 60 (12) 0.15
  Neutral 53 (16)
  Helpful/very helpful 52 (12)
GP general practitioner; SD standard derivation
Fig. 1 Perceptions on antibiotic use and antibiotic resistance
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to train other HCWs at different level of healthcare 
institutions.
Drivers of ABR include lack of education of HCWs, 
beliefs, attitudes, and knowledge of HCWs on appro-
priate antibiotic use and ABR among others [6]. Most 
respondents in this study consider that issues of antibiotic 
overuse and ABR are more important nationwide than in 
their daily practice. This externalisation of responsibility, 
reported in several studies, can potentially maintain anti-
biotic misuse as physicians might be reluctant to change 
their habits [19, 20]. Regardless of their knowledge score, 
most participants feel confident that they use antibiotics 
optimally. This high level of confidence has been reported 
in similar studies with senior doctors feeling more confi-
dent than junior doctors in antibiotics prescribing [21]. 
We found that the level of confidence was not associated 
with age, experience, or specialty. High level of confi-
dence could explain the externalisation of responsibility 
regarding ABR and could be a driver of antibiotic over-
use. These data emphasize the need for more education 
with effective strategies on behavioural changes.
Encouragingly, whereas a study conducted in DRC 
found that the majority of respondents disagreed that 
inappropriate use of antibiotics can harm patients, two 
Fig. 2 Attitudes of prescribers on antibiotic use and antibiotic resistance
Table 4 Factors influencing antibiotic use (N = 73)
Parameters/Attitude Strongly influence/influence 
n (%)
Neutral n (%) Do not influence at 
all/do not influence 
n (%)
Personal previous experience 61 (84) 7 (10) 5(7)
Guidelines 73 (100) 0 0
Patient expectation 14 (19) 7 (10) 52 (71)
ABR profile in the ward 53 (73) 16 (22) 4 (6)
Risk of missing an infection 46 (63) 12 (16) 15 (21)
Patient critically ill/immunocompromised 66 (90) 3 (4) 4 (6)
Pharmaceutical company pressure 46 (63) 16 (22) 11 (15)
Cost/effectiveness ratio 70 (96) 1 (1) 2 (3)
Quality of drug 72 (99) 1 (1) 0
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thirds of doctors in our cohort perceived this as a threat 
to patients’ safety [11]. Inappropriate use of antibiot-
ics has been associated with selection of drug-resistant 
bacteria, leading to severe infections, delayed clinical 
response, prolonged hospitalisations, and exposure to 
drug side effects [22].
Patient expectation has been found to influence antibi-
otic prescription as shown in a study on antibiotic pre-
scription for respiratory tract infections which revealed 
that physicians prescribe more antibiotics when they 
perceive a desire from the patient [6, 23]. In the present 
study, only one fifth of doctors confirmed being influ-
enced by patients, which is far lower compared to other 
studies [19, 24]; nevertheless, prescribers not influenced 
by patients’ expectations had a better knowledge score. 
Previous studies have shown that prescribers who are not 
influenced by patient pressure for antibiotic prescribing 
demonstrated better antibiotic prescribing practice [20, 
25].
The WHO reports that “globally, most prescribers 
receive most of their prescribing information from the 
pharmaceutical industry and in many countries, this is 
the only information they receive” [26]. Our data show 
that for more than 60% of participants, antibiotic pre-
scribing is influenced by pharmaceutical firms with only 
a third who had received education or training on antibi-
otics spectrum of activity and indications in the last year. 
The absence of local guidelines and regulation on HCW-
pharmaceutical firms’ relationship could explain these 
findings. A systematic review on physicians’ interaction 
with pharmaceutical firms and association with their 
clinical practices revealed that doctors exposed to phar-
maceutical companies prescribed more drugs and had a 
suboptimal prescribing quality [27]. In developed coun-
tries, several restrictions have been set regarding remu-
neration of doctors or funding by pharmaceutical firms 
[28, 29]. However, efforts to avoid antibiotics prescribing-
related perverse incentives and misconduct are needed in 
LMICs.
The knowledge level of the doctors in this cohort is 
somewhat lower than that found in similar studies 
conducted in DRC and USA [11, 30]. It is important 
to mention that about a quarter of doctors scored less 
than 50%. The lowest scores obtained were on manage-
ment of ESBL Gram-negative infections, peri-operative 
prophylaxis, antibiogram interpretation and antibio-
therapy de-escalation. The lack of local guidelines as 
well as insufficient ID specialists and training could 
explain these findings; all limitations that have been 
highlighted by participants. Specialists scored better 
than residents and GPs, although it did not reach statis-
tical significance. The score was not influenced by age, 
experience, category, place of work or previous training 
on antibiotic use and ABR. Similar results have been 
described in previous studies where junior doctors’ 
knowledge on antibiotic resistance was not different to 
that of senior doctors [31]. Surprisingly, participants 
who do not use textbooks as primary resources for 
antibiotics prescribing scored significantly better than 
those who do. This is perhaps due to more up-to-date 
content in other tools compared to textbooks. Never-
theless, this interesting finding would need to be con-
firmed in a larger sample.
Limitations to this study include the small size of our 
cohort, due to the relatively low response rate. Although 
this phenomenon is inherent to web based KAP studies, 
it can be partly explained in our study by limited access to 
internet. This could limit the generalisation of our results 
to the entire country. As previously shown in KAP stud-
ies, the respondents in this study may have had tendency 
to provide ‘socially desirable’ answers. This type of stud-
ies also provides reported instead of observed practice 
and the interviewees might adapt their answers to the 
context. To minimise the potential biases, we stressed on 
complete respondent’s confidentiality in our survey. We 
have also recommended respondents to take the ques-
tionnaire individually and not as a group. We believe that 
studies on larger cohorts at different levels of care, and in 
a wider variety of HCWs are ideally needed to confirm 
our findings. Confirmation of these data may help inform 
national policies on appropriate antibiotic use and ABR 
in Cameroon. Further research on the most effective 
tools for education of HCWs with focus on increasing 
knowledge on ABR should be conducted.
Conclusion
This study has highlighted gaps in the knowledge, atti-
tudes, and perceptions toward ABR and antibiotic use 
of medical doctors working at the highest level of the 
healthcare system in Cameroon. The low level of knowl-
edge of prescribers contrasts with their high confidence 
in appropriate use of antibiotics. Additionally, their 
non-recognition of ABR as a problem in their ward or 
hospital is worrisome. Establishment of local guidelines 
as well as antibiotic stewardship programmes and other 
educational tools could be a way to improve the use of 
antibiotics and ABR.
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Standard deviation; USA: United States of America; UTI: Urinary tract infection; 
WHO: World Health Organization.
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